コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 well as reference genomes of Chimpanzee and Rhesus Macaque.
2 rons in the BNSTALG from the mouse, rat, and rhesus macaque.
3 owing low-dose, repeated rectal challenge of rhesus macaques.
4 uman MD system using fMRI connectivity in 35 rhesus macaques.
5 o a CD4-mimetic miniprotein (gp140-M64U1) in rhesus macaques.
6 ency virus (SHIV)-infected and 16 uninfected rhesus macaques.
7 -producing cells in chronically SIV-infected rhesus macaques.
8 in boost vaccination regimens were tested in rhesus macaques.
9 V1 neutralizing sera from immunized mice and rhesus macaques.
10 anti-IL-15 mAb on T and NK cell dynamics in rhesus macaques.
11 deficiency virus (HIV) vaccine strategies in rhesus macaques.
12 tion of corticothalamic projections in awake rhesus macaques.
13 aining formulation of RiVax and tested it in rhesus macaques.
14 e of the parental bNAbs when administered to rhesus macaques.
15 ion in mouse colitis models and SIV-infected rhesus macaques.
16 ein (Env)-specific B and T cell responses in rhesus macaques.
17 of progression to AIDS in SIVmac251-infected rhesus macaques.
18 s of leukocyte gene regulation in humans and rhesus macaques.
19 n AMs in BAL fluid and IMs in lung tissue of rhesus macaques.
20 using scalp electroencephalography (EEG) in rhesus macaques.
21 B cell infection on oral viral challenge in rhesus macaques.
22 d to more rapid disease progression than are rhesus macaques.
23 ematopoietic macrophages from adult, healthy rhesus macaques.
24 immunodeficiency virus (SHIV) replication in rhesus macaques.
25 virus responsible for simian AIDS (SAIDS) in rhesus macaques.
26 lsion (CNE) delivery system was evaluated in rhesus macaques.
27 without gp140 boost in aluminum hydroxide in rhesus macaques.
28 ctal and intravaginal SIVsmE660 challenge of rhesus macaques.
29 rsistent infection after oral inoculation of rhesus macaques.
30 R) to characterize drusenoid lesions in aged rhesus macaques.
31 irus transmission through mucosal contact in rhesus macaques.
32 l plasma cell frequency in vaccinated female rhesus macaques.
33 r levels of Gag-specific immune responses in rhesus macaques.
34 ficiency Virus (SIV)-infected and uninfected rhesus macaques.
35 s; 5 mg/kg, oral, twice daily) and untreated rhesus macaques.
36 enhance protection from a SHIV challenge in rhesus macaques.
37 lays ZIKV replication to peak viral loads in rhesus macaques.
38 es than RD-Ad vectors in Syrian hamsters and rhesus macaques.
39 ctively, and performed a protection study in rhesus macaques.
40 onferred protection against ZIKV in mice and rhesus macaques.
41 t of the Mamu-B*008 allotype in SIV-infected rhesus macaques.
42 MDSC frequency and function in SIV-infected rhesus macaques.
43 temporal lobe of cognitively assessed, aged rhesus macaques.
46 unodeficiency virus (anti-SIV) activity into rhesus macaques 3 days following an intrarectal SIV inoc
47 f elite control in SIV-infected Mamu-B*08(+) rhesus macaques-a model of HLA-B*27-mediated elite contr
49 te the memory B cell Ig repertoires from two rhesus macaques after five serial immunizations with Env
50 allenge stock in vitro, protected 6 out of 7 rhesus macaques against infection while the antibody 3BN
53 orted from vaccine-draining lymph nodes from rhesus macaques also showed expression of HLA-DR and wer
54 of L. plantarum-containing healthy and SIV+ rhesus macaques also transcribed genes for host glycan m
56 variation in the absence of autopsy data, a rhesus macaque and common marmoset model of MERS-CoV dis
58 simian immunodeficiency virus (SIV)-infected rhesus macaques and acute ethanol intoxication in a muri
59 of mAbs elicited by a model Env immunogen in rhesus macaques and comprehensively characterized their
60 adaptation may allow robust HCV infection in rhesus macaques and creation of a new animal model for s
61 ssess vaccine-induced antibodies, from mice, rhesus macaques and human clinical trials, for their fun
62 human immunodeficiency virus (SHIV)-infected rhesus macaques and human immunodeficiency virus type 1
63 use functional magnetic resonance imaging in Rhesus macaques and humans to examine the brain regions
64 netic and physiological similarities between rhesus macaques and humans, our results provide novel in
66 constructed an arrayed library of ISGs from rhesus macaques and tested the ability of hundreds of in
67 these vectors into the cerebellar cortex of rhesus macaques and tested vector efficacy in three ways
69 bidity and mortality affecting the supply of rhesus macaques and, potentially, their responses to exp
70 ed rhesus macaques, the heart of one treated rhesus macaque, and adjacent to a peripheral nerve of an
71 d comparative epigenetic profiling of human, rhesus macaque, and mouse corticogenesis to identify pro
72 ary hepatocytes from mice, rats, dogs, pigs, rhesus macaques, and cynomolgus macaques were transduced
73 Four T/F virus strains were inoculated into rhesus macaques, and each exhibited typical SIV replicat
74 tudy, we isolated and identified exosomes in rhesus macaques, and investigated their effects on cell
75 arily, hepatocytes from cynomolgus macaques, rhesus macaques, and pigs became fully susceptible to HB
76 ulatory cells in lymphoid tissues of healthy rhesus macaques, and we studied their dynamics throughou
77 s a novel and significant enhancement to the rhesus macaque animal model where both the clinical util
80 onhuman primate model of VZV infection where rhesus macaques are intrabronchially challenged with the
85 ting function in lymph nodes of SIV-infected rhesus macaques associated with diminished IL-12 and IFN
86 cy virus (SIV) infection, we necropsied male rhesus macaques at 1, 3, 7, and 14 days after penile SIV
87 reening assessment was performed on 10 adult rhesus macaques at baseline and every 4-6 months for 2 y
88 in the rectal draining lymph nodes (dLNs) of rhesus macaques at different times after intrarectal ino
89 e our understanding of why EBV cannot infect rhesus macaques by proving that viral attachment through
90 We tested this prediction in two healthy rhesus macaques by recording single-unit spiking activit
91 virus with the restored pentameric complex, rhesus macaques can develop broadly neutralizing antibod
94 longitudinally-collected plasma samples from rhesus macaques challenged via intramuscular and aerosol
95 infections with diverse viruses in a captive rhesus macaque colony and identifies several viruses pos
96 f broadly neutralizing antibodies (bnAbs) in rhesus macaques, commonly used to assess vaccine immunog
97 ently accumulate in chronically SIV-infected rhesus macaques compared with those infected with less p
100 stinct spatial behaviors from young and aged rhesus macaques: constrained space (CAGE), head-restrain
101 paring network organization of the mouse and rhesus macaque cortical connectome derived from complete
103 acious in delaying the onset of SIVmac251 in rhesus macaques, despite the higher immunogenicity of th
106 that PFC cells recorded from male and female rhesus macaques during a complex task show a moderate le
107 and cytokines were assessed in therapy-naive rhesus macaques during early and chronic stages of SIV i
110 elicit more potent and balanced responses in rhesus macaques, even with various simpler immunization
111 as obtained from 110 PMv neurons in two male rhesus macaques executing four reach-grasp-manipulate ta
117 IM5alpha restriction when it was passaged in rhesus macaques expressing restrictive TRIM5alpha allele
118 eviously reported that in mice, gerbils, and rhesus macaques, expression of babA is lost, either by p
121 ct using serial in utero MRI measurements of rhesus macaque fetuses, from which macroscopic and cellu
122 ortex is longitudinally characterized in the rhesus macaque, focusing on gestation day (G85) through
123 sequentially imaged CD4(+) cell recovery in rhesus macaques following total body irradiation (TBI) a
125 es to multiple virus and vaccine antigens in rhesus macaques for years after sustained memory B cell
126 before and following SIV infection protected rhesus macaques from developing AIDS and partially from
127 d from a human subject (AD358) and a Chinese rhesus macaque (GB40) displayed no or limited neutralizi
130 erstanding of extant genomic variation among rhesus macaques has implications for the use of this spe
132 nt replication in vivo, we engrafted primary rhesus macaque hepatocytes into immunocompromised xenore
134 ons up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related
136 monocyte-derived macrophages (MDMs) between rhesus macaques, i.e., experimental SIV hosts in which t
137 cell sorting from the peripheral blood of a rhesus macaque immunized with YU2gp140-F trimers in adju
138 lar and humoral immune responses elicited in rhesus macaques immunized with two poxvirus vectors (NYV
139 e-cell recordings from the IO of young adult rhesus macaques in acutely prepared brainstem slices, ou
140 and bronchoalveolar lavage fluid of AGMs and rhesus macaques (in which CD4 downregulation is not obse
141 lonization of the upper respiratory tract of rhesus macaques, in some cases associated with stimulati
143 during persistent infection was analyzed in rhesus macaques infected long term with RhCMV to determi
145 evaluated the pathogenicity and shedding in rhesus macaques infected with 1 of 2 West African isolat
146 s the viral kinetics and immune responses in rhesus macaques infected with a clinical ZIKV Brazilian
148 s were measured in longitudinal samples from rhesus macaques infected with either SIVmac251 (progress
150 some aspects of human infections.IMPORTANCE Rhesus macaque infection with simian immunodeficiency vi
152 previously showed that in early SIV-infected rhesus macaques intestinal dysfunction is initiated with
153 Paradoxically, control of this virus in rhesus macaques is only partial, and progression to AIDS
156 lso detected on a small population of DCs in rhesus macaque (Macaca mulata) mesenteric lymph node.
161 or cortical and forearm muscular activity of rhesus macaques (Macaca mulatta) as they reached, graspe
162 patterns and motor cortical spiking data in rhesus macaques (Macaca mulatta) handling objects of var
164 we measured the looking time of 3-month-old rhesus macaques (Macaca mulatta) viewing macaque faces v
165 s and consequences of natal dispersal age in rhesus macaques (Macaca mulatta), a species with male di
171 ystem of humans, the squirrel monkey and the rhesus macaque, making comparisons with past results fro
175 ccines have shown remarkable efficacy in the rhesus macaque model of acquired immune deficiency syndr
176 challenge with wild-type (WT) SIV in the SIV-rhesus macaque model of HIV-1 transmission to women.
178 In the present study, we used a relevant rhesus macaque model of infection with simian immunodefi
181 ells now opens an opportunity to use the SIV/rhesus macaque model to further elucidate the potential
189 within the brain from two well-characterized rhesus macaque models of the neurological complications
191 in 2F5 bnAb VHDJH and VLJL knock-in mice and rhesus macaques modified KYNU activity or disrupted tiss
192 tory cortex (A1) under two conditions: while rhesus macaque monkeys (Macaca mulatta) actively perform
194 t-tonic neurons in the nucleus prepositus of rhesus macaque monkeys using eight-channel linear microe
195 of seven species-human, chimpanzee, gorilla, rhesus macaque, mouse, rat, and dog-to investigate epige
196 stered vaccines to six groups of infant male rhesus macaques (n = 12-16/group) using a standardized t
200 ct between task goals and distractors in the rhesus macaque, particularly for biologically relevant s
203 populations in primary auditory cortex while rhesus macaques performed a novel feature-selective atte
204 etal (LIP) and middle temporal (MT) areas of rhesus macaques performing a motion direction discrimina
205 ateral prefrontal cortex (dlPFC) of two male rhesus macaques performing a task that elicited key aspe
206 neurons in dorsolateral PFC (DLPFC) of male rhesus macaques performing rule-guided prosaccades and a
208 cytic receptors on dendritic cells (DCs), in rhesus macaques primed with a poxvirus vector (NYVAC-KC)
209 simian immunodeficiency virus (SIV)-infected rhesus macaque provides a powerful model for the study o
210 Therefore, Asian-lineage ZIKV infection of rhesus macaques provides a relevant animal model for stu
212 simian immunodeficiency virus (SIV)-infected rhesus macaques received antibiotics followed by FMT.
214 virus (SIV) acquisition in three independent rhesus macaque repeated low-dose rectal challenge studie
215 e applied HIV-1 and SEVI to intact human and rhesus macaque reproductive tract tissues to determine h
217 Zika virus directly to the tonsils of three rhesus macaques results in detectable plasma viremia in
218 Whole-genome sequencing analysis of 133 rhesus macaques revealed more than 43.7 million single-n
219 ization studies in mice, Guinea pigs, and in Rhesus macaques, revealed that LNPs induced high titers
220 lls from peripheral blood and the jejunum in rhesus macaques, revealing distinct expression patterns
221 d herpesvirus (KSHV) and the closely related rhesus macaque rhadinovirus (RRV) are the only viruses k
222 's sarcoma-associated herpesvirus (KSHV) and rhesus macaque rhadinovirus (RRV), are unique in that th
224 mmon nonhuman primate species, Indian-origin rhesus macaques (RM) and Mauritian-origin cynomolgus mac
225 do not develop disease, whereas infection of rhesus macaques (RM) causes CD4(+) T cell loss and AIDS.
227 simian immunodeficiency virus (SIV)-infected rhesus macaques (RM), CD4(+) TSCM are preserved in numbe
228 of IL-7 could reverse TN deficiency in aging rhesus macaques (RM), either by enhancement of the demon
232 sive transfer of HIV-specific nAbs protected rhesus macaques (RMs) from subsequent mucosal challenge
233 simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) shows that these cells contribute
235 port show that intrabronchial inoculation of rhesus macaques (RMs) with VZV resulted in an abortive V
236 hown that during pathogenic SIV infection of rhesus macaques (RMs), rapid disease progression is asso
237 ccine induced a similar antibody response in rhesus macaques (RMs), which are commonly used as an ani
243 d the effects of hormone replacement in aged rhesus macaques, soon after surgically-induced menopause
244 m the major simian immunodeficiency virus of rhesus macaque, sooty mangabey, and HIV-2 (SIVsmm/SIVmac
245 aluated using 12 weekly rectal challenges in rhesus macaques subgrouped by tripartite motif-containin
246 (SIV) infection in vervet monkeys but not in rhesus macaques, suggesting that part of the signal refl
248 cells in a unique cohort of SIV-controlling rhesus macaques that maintained low to undetectable leve
249 twice-weekly rectal SHIV162p3 challenges in rhesus macaques that received either placebo (n = 7), MV
250 chemically induced colitis in SIV-uninfected rhesus macaques that we developed using dextran sulfate
251 e or in combination with the bnAb PGT121, in rhesus macaques that were chronically infected with SHIV
252 nal nerves, and dorsal root ganglia (DRG) of rhesus macaques that were inoculated intrathecally with
253 ain insight into these questions, we studied rhesus macaques that were vaccinated with SIVmac239 and
254 nstrate, in closed-loop experiments with two rhesus macaques, that after the loss of approximately 60
256 s were observed in the brains of two treated rhesus macaques, the heart of one treated rhesus macaque
258 ewise, Mamu-B*08 expression also predisposes rhesus macaques to control simian immunodeficiency virus
259 py in simian immunodeficiency virus-infected rhesus macaques to determine whether decreased TZ fibros
260 , and the female reproductive tract (FRT) of rhesus macaques to determine whether these cells contrib
261 with a social status manipulation in female rhesus macaques to investigate how status alters immune
263 keys are susceptible to resistance by common rhesus macaque TRIM5alpha alleles and result in reduced
264 riction of retroviruses by human TRIM5alpha, rhesus macaque TRIM5alpha, and owl monkey TRIM-Cyp remai
265 ction factors in primary CD4(+) T cells from rhesus macaques under various conditions, finding dynami
267 re identified in SIV p27(Gag) Analysis of 31 rhesus macaques vaccinated with full-length SIV gag pDNA
268 V neutralization panel and samples from four rhesus macaque vaccine trials designed for cross compari
272 gnaling and chemotaxis in vitro Six infected rhesus macaques were infused with differentially fluores
281 ficiently utilizes human CD4 than the CD4 of rhesus macaques, whereas the closely related virus SIVma
282 e effect of primate FH binding, we immunized rhesus macaques with a 4-component serogroup B vaccine (
283 In this study, we report that coimmunizing rhesus macaques with HIV-1 gp160 DNA and gp140 trimeric
284 from atraumatic rectal inoculation of Indian rhesus macaques with low doses of SIVmac251 or SIVsmE660
285 Further, vaccination of RhCMV-uninfected rhesus macaques with nonfunctional forms of RhCMV vIL-10
286 Our results demonstrate that immunization of rhesus macaques with NP adjuvants mixed with soluble SIV
287 for the prevention of Ebola virus disease in rhesus macaques with regards to reduction of viral load,
295 rrent study, we evaluated the performance of rhesus macaques with ventral striatum (VS) lesions on a
296 VS) and amygdala to appetitive RL, we tested rhesus macaques with VS or amygdala lesions on determini
300 antibodies to multiple neutralizing sites in rhesus macaques, with quality attributes comparable to t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。